Lord Dowding Fund for humane research

 

National Antivisection Society

Response to the statement of the EU Scientific Steering Committee

12 July 2007

1

on the use of non-human primates (NHP) in biomedical research

A briefing paper for Members of the European Parliament

The European Unionís Scientific Steering Committee (SSC) produced a scientific opinion paper in 2002 on the use of non-human primates (NHP) in biomedical research. This paper made a series of statements about scientific research on NHP, and it has informed the EUís decision-making process on the matter.

In this briefing for MEPs by Animal Defenders International (ADI), the National Anti-Vivisection Society (NAVS) and the Lord Dowding Fund for Humane Research (LDF) addresses each of the statements made by the SSC. We discuss current scientific opinion on the issues raised, and the scientific basis for adopting non-animal alternatives in biomedical research.

The statements made by SSC are given, followed by the response from ADI/NAVS/LDF.

1. Scientific Steering Committee ĎStatementí section

2. The Scientific Steering Committee position: safety and efficacy/species differences & ADIís Response

3. The Scientific Steering Committeeís five examples of diseases of concern:

SSC: problems faced in developing vaccines or therapeutics:

The SSC included research on TSE in its introduction, citing research on these diseases of the brain to justify the use of non-human primates in research:

References

© National Anti-Vivisection Society